FDA Issues Qualified Health Claim Related to Yogurt, Type 2 Diabetes
By Denny Jacob
The U.S. Food and Drug Administration doesn't intend to object to certain health claims surrounding yogurt and type 2 diabetes.
The FDA said in a letter of enforcement discretion that it won't object to certain qualified health claims related to yogurt consumption and reduced risk of type 2 diabetes provided that the qualified health claims are worded in a way that doesn't mislead consumers, among other considerations.
A qualified health claim is supported by scientific evidence but doesn't meet the more rigorous "significant scientific agreement" standard required for an authorized health claim, the regulator said.
The FDA responded to a qualified health claim petition submitted on behalf of Danone North America. After reviewing the petition and other evidence related to the claim, it determined that there is some credible evidence supporting a relationship between yogurt intake and reduced risk of type 2 diabetes but that the evidence is limited.
"We know that a growing body of research suggests regular yogurt consumption could reduce your risk of developing one of the most significant and rapidly rising health ailments in the United States. That's why we decided to submit a petition for this first-of-its-kind qualified health claim," said Miguel Freitas, vice president of health and scientific affairs at Danone North America.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
March 01, 2024 15:57 ET (20:57 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks